FilingSEC EDGAR8-K
Unicycive Therapeutics Resubmits NDA and Appoints New Director
· SEC accepted
StageNDA Resubmission
Filing content
The company resubmitted its NDA for OLC to resume the FDA approval process and appointed biopharmaceutical industry veteran Meredith S. Manning to its board of directors.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…